Kurma Partners logo

Kurma Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

6

Common Fundraising Type

Series A

Coave Therapeutics logo
Coave Therapeutics

Genetic medicines

UI Investissement logo
Turenne Capital logo
Seroba Life Sciences logo
Omnes Capital logo
Novo Holdings logo
Kurma Partners logo
Invus logo
Fund+ logo

Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.

Series A
$33M
01/09/2025
Article
Radiium logo
Radiium

AI-powered

Newfund logo
Kurma logo
Founders Future logo
Galion.exe logo
European EIC Fund logo

Raidium is a French medtech startup that develops AI-powered precision diagnostics technology for advanced 3D segmentation and automated analysis in radiology.

Seed
$13M
12/02/2024
Article
PanTera logo
PanTera

Radioisotope production

EQT Life Sciences logo
Paladin logo
PMV logo
Kurma Partners logo
Korys logo
Eurazeo logo
SFPIM logo
IBA logo

PanTera is a Belgian company focused on producing the radioisotope actinium-225 for use in Targeted Alpha Therapy for cancer treatment.

Hybrid A
$139.7M
09/11/2024
Article
Poppins logo
Poppins

Healthtech

Verve Ventures logo
Kurma Partners logo
HEC Ventures logo
Eurazeo logo
Bpifrance logo
BNP Paribas Développement logo
Allianz France logo

Poppins develops digital therapeutic musical video games for children with neurodevelopmental disorders, such as dyslexia and dyscalculia, and has raised €8 million in funding to expand their program and support further research.

Equity
$8.4M
10/18/2023
Article
Shorla Oncology logo
Shorla Oncology

Pharmaceutical

Seroba Life Sciences logo
Kurma Partners logo
Enterprise Ireland logo

Shorla Oncology is a pharmaceutical company that develops oncology drugs for orphan and pediatric cancers, with a focus on addressing drug shortages and improving the preparation and application of oncology medication.

Series B
$35M
10/04/2023
Article
Corteria Pharmaceuticals logo
Corteria Pharmaceuticals

Biopharmaceuticals

OrbiMed logo
Jeito Capital logo
V-Bio Ventures logo
Omnes Capital logo
Kurma Partners logo
Invivo Capital logo
Fountain Healthcare Partners logo

Corteria Pharmaceuticals is a biopharmaceutical company that develops first-in-class therapies for unaddressed heart failure subpopulations, with a focus on multi-organ benefits targeting the kidneys, heart, and vessels.

Series A
$69.6M
09/07/2023
Article